NEW YORK (GenomeWeb News) – The Damon Runyon Cancer Research Foundation has awarded $2.3 million to fund several early-career scientists who are developing novel technologies for diagnosing, preventing, and treating cancer, DRCR said yesterday.

The new Damon Runyon Rachleff Innovation Award winners each will receive $450,000 over three years to pursue projects involving a range of molecular, genomic, and other research tools for combating cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.